incretin mimetics glp 1 agonists GLP-1’s (incretin mimetics), This type of medication works by increasing the levels of hormones called ‘incretins’. These hormones help the body produce more insulin only when needed and reduce the The Influence of Glucagon-like Peptide-1

Buse JB, Bain SC, Mann JF, et al

Potential benefits and harms must be balanced with any medical treatment, Bian said

In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination

Figure 36: Novo Nordisk originated from Nordisk Insulin Laboratorium, a company founded in 1923 by Birte Marie Krogh (photographed here, credit: Novo Nordisk) and her husband August Krogh to commercialise the production of insulin from animal pancreata